Protocol summary
-
Study aim
-
Comparison of the effect of hyoscine and EMLA cream on Catheter related bladder discomfort in non-urological surgery
-
Design
-
Two arm parallel group randomized trial with blinded participants, outcome assessment and statistical analyst.
-
Settings and conduct
-
The study will assess the effectiveness of Hyoscine on CRBD compared to the EMLA group. The participants will assign equally to the groups. This study will carry out at Bohlool Hospital affiliated to Gonabad University of Medical Sciences. The participants, outcome assessment and statistical analyst will blind to the groups.
-
Participants/Inclusion and exclusion criteria
-
Having ASA class 1 or 2 , 18 to 60 years old, Elective surgery, general anesthesia and requires urinary catheterization, No history of bladder obstruction, overactive bladder, kidney and liver diseases, chronic pain, cerebrovascular disorders, cardiovascular diseases, psychosis, neurological bladder. Non-urological surgeries. No history of allergy to lidocaine or prilocaine and hyoscine, No cardiac dysrhythmia. No obvious cognitive impairment
Do not take sedatives for a long time. No kidney or liver failure. No history of drug use. No untreated glaucoma, active bleeding, Paralytic ileus, chronic lung disease and secondary tachycardia due to heart failure. Medications used before and during anesthesia should be the same.
Unwillingness to cooperate. Patients should also undergo urological surgery during the operation.
Any effective intervention or medication in addition to medications used in the routine anesthesia process
-
Intervention groups
-
group 1: Hyoscine N-butyl bromide, at a dose of 20 mg intravenously within one minute before extubating. group 2, 5 g of EMLA cream and group 3 (control): 5 g of Lidocaine jell, both of these is made in Iran, applicating before placing a urinary catheter for a patient
-
Main outcome variables
-
Incidence of CRBD
General information
-
Reason for update
-
Adding control group to study, changing the measurement time and modifying randomization mode and sample size
-
Acronym
-
CRBD
-
IRCT registration information
-
IRCT registration number:
IRCT20210228050530N1
Registration date:
2021-04-07, 1400/01/18
Registration timing:
prospective
Last update:
2021-06-03, 1400/03/13
Update count:
1
-
Registration date
-
2021-04-07, 1400/01/18
-
Registrant information
-
-
Recruitment status
-
Recruitment complete
-
Funding source
-
-
Expected recruitment start date
-
2021-04-21, 1400/02/01
-
Expected recruitment end date
-
2021-08-22, 1400/05/31
-
Actual recruitment start date
-
empty
-
Actual recruitment end date
-
empty
-
Trial completion date
-
empty
-
Scientific title
-
Comparison of the effect of hyoscine and EMLA cream on Catheter related bladder discomfort (CRBD) in patients undergoing non-urologic surgery
-
Public title
-
The effect of hyoscine and EMLA cream on Catheter related bladder discomfort (CRBD)
-
Purpose
-
Prevention
-
Inclusion/Exclusion criteria
-
Inclusion criteria:
Having ASA class 1 or 2 according to the anesthesiologist record
Age between 18 and 60 years
Elective surgery with general anesthesia and requires urinary catheterization
No history of bladder obstruction, overactive bladder, severe kidney and liver diseases, chronic pain, cerebrovascular disorders, cardiovascular diseases, psychosis, neurological bladder
Non-urological surgeries.
No history of allergy to lidocaine or prilocaine and hyoscine
No cardiac dysrhythmia
No obvious cognitive impairment
Do not take sedatives for a long time
No kidney or liver failure
No history of drug use
No untreated glaucoma, active bleeding, Paralytic ileus, chronic lung disease and secondary tachycardia due to heart failure
Medications used before and during anesthesia should be the same
Exclusion criteria:
Unwillingness to cooperate
Patients should also undergo urological surgery during the operation.
Any effective intervention or medication in addition to medications used in the routine anesthesia process
-
Age
-
From 18 years old to 60 years old
-
Gender
-
Both
-
Phase
-
3
-
Groups that have been masked
-
- Participant
- Outcome assessor
- Data analyser
-
Sample size
-
Target sample size:
105
-
Randomization (investigator's opinion)
-
Randomized
-
Randomization description
-
After obtaining written consent from the participants, the patients were selected through purposive sampling method and were randomly assigned to control and intervention groups based on the permutation blocks method. To do this, the letter C, B and A will be considered for the 2% lidocaine gel (control group), EMLA and Hyoscine + lidocaine groups, respectively. Possible modes in permutation blocks method are six modes include (BCA, ACB, ABC, BAC, CBA, and CAB). Each mode will be written on a card and the cards will be assigned the number one to six. Then 35 mode is selected by using a table of random numbers, 35 numbers between 1 and 6 will be selected. The resulting blocks will be listed in order. Then, based on the list, the selected patients are divided into three groups. In order to homogenize the gender, a separate list is prepared for each of those.
-
Blinding (investigator's opinion)
-
Triple blinded
-
Blinding description
-
Prior to anesthesia and allocation to groups, for participants who meet the inclusion criteria will be described control and two intervention groups. The participants will be explained that they will allocate into two interventions or control groups. At the end of the study, they are informed about their group.
The evaluator of primary (CRBD) and secondary outcomes (severity of CRBD) will be a person (Apart from the main researchers) who does not know the patient is in the intervention or control groups.
One, two and three will assign to two interventions and control groups, respectively. Therefore, the statistical analyst will not aware of the study groups and only will know the groups as a code.
-
Placebo
-
Not used
-
Assignment
-
Parallel
-
Other design features
-
Ethics committees
1
-
Ethics committee
-
-
Approval date
-
2021-02-27, 1399/12/09
-
Ethics committee reference number
-
IR.GMU.REC.1399.125
Health conditions studied
1
-
Description of health condition studied
-
Catheter related bladder discomfort
-
ICD-10 code
-
N32.8
-
ICD-10 code description
-
Other specified disorders of bladder
Primary outcomes
1
-
Description
-
Incidence of Catheter related bladder discomfort
-
Timepoint
-
In one, two, three and four hours after the end of anesthesia
-
Method of measurement
-
Checklist for the incidence of Catheter related bladder discomfort
Secondary outcomes
1
-
Description
-
Severity of CRBD
-
Timepoint
-
In one, two, three and four hours after the end of anesthesia.
-
Method of measurement
-
Checklist of severity of CRBD of Catheter related bladder discomfort
Intervention groups
1
-
Description
-
Intervention group 1: Hyoscine N-butyl bromide made in Iran, Elixir Company, at a dose of 20 mg intravenously within one minute before extubating of a patient under non-urological surgery.
-
Category
-
Prevention
2
-
Description
-
Intervention group 2: 5 g of EMLA cream made in Iran, Iran Daroo Company before placing a urinary catheter for a patient undergoing non-urological surgery
-
Category
-
Prevention
3
-
Description
-
Control group: 5 g lidocaine jell made in Iran, Iran Daroo Company before placing a urinary catheter for a patient undergoing non-urological surgery
-
Category
-
Prevention
1
-
Sponsor
-
-
Grant name
-
-
Grant code / Reference number
-
-
Is the source of funding the same sponsor organization/entity?
-
No
-
Title of funding source
-
Gonabad University of Medical Sciences
-
Proportion provided by this source
-
100
-
Public or private sector
-
Public
-
Domestic or foreign origin
-
Domestic
-
Category of foreign source of funding
-
empty
-
Country of origin
-
-
Type of organization providing the funding
-
Academic
Sharing plan
-
Deidentified Individual Participant Data Set (IPD)
-
Yes - There is a plan to make this available
-
Study Protocol
-
No - There is not a plan to make this available
-
Statistical Analysis Plan
-
No - There is not a plan to make this available
-
Informed Consent Form
-
No - There is not a plan to make this available
-
Clinical Study Report
-
Yes - There is a plan to make this available
-
Analytic Code
-
No - There is not a plan to make this available
-
Data Dictionary
-
No - There is not a plan to make this available
-
Title and more details about the data/document
-
Thesis report
All research information will be published after being unidentified.
-
When the data will become available and for how long
-
Since 1401
-
To whom data/document is available
-
Everyone can request research results.
-
Under which criteria data/document could be used
-
Upon formal request through other members of the research team
-
From where data/document is obtainable
-
Library of Gonabad University of Medical Sciences
-
What processes are involved for a request to access data/document
-
An official request to Gonabad University of Medical Sciences
-
Comments
-